Pembrolizumab plus enfortumab vedotin in urothelial cancer.
Matteo SantoniHideki TakeshitaFrancesco MassariAristotelis BamiasLinda CerboneOndrej FialaVeronica MollicaSebastiano ButiAngela SantoniJoaquim BellmuntPublished in: Nature reviews. Urology (2024)